Arcellx develops novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.

Register for Details

For more details on financing and valuation for Arcellx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Arcellx's ticker symbol?


What is Arcellx's stock price?

34.65 as of 9/26/23

Arcellx Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
4/13/2021 Series C $120MM raised $XXX.XX $XXX.XX
10/3/2019 Series B-1 and B-2 $85.68MM raised $XXX.XX $XXX.XX
9/1/2017 Series A $29.8MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Arcellx

Forge green plus iconForge green minus icon

What is Arcellx funding to date?

Arcellx has raised $235.48MM to date.
Forge green plus iconForge green minus icon

When was Arcellx founded?

Arcellx was founded in 2014.
Updated on: Jun 12, 2022